influenza PB2 inhibitors (Johnson & Johnson/Diamond Light Source/Charles River Laboratories International)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameinfluenza PB2 inhibitors (Johnson & Johnson/Diamond Light Source/Charles River Laboratories International)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase basic protein 2 inhibitors
TargetsPolymerase basic protein 2
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCharles River Laboratories International IncDiamond Light Source LtdJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A